Elizabeth’s Hope has a unique mission: It provides funding for cutting-edge personalized medicine to children and adolescents with rare and operable brain cancers at Weill Cornell Medicine. Using a state-of-the-art gene sequencing machine and a team of scientists — including surgeons, molecular geneticists, pathologists, and bioinformatics researchers — the Weill Cornell Pediatric Brain and Spine Center is able to identify the best treatment for each young patient, using methods that are currently either unavailable or cost-prohibitive for many families. In a simultaneous effort, the team is working to test innovative new delivery methods that bypass the blood-brain barrier and strike directly at tumors with the therapeutic agent identified as being most effective against that particular tumor.
Research funded by Elizabeth’s Hope will focus on rare tumors like gliomatosis cerebri, which is what claimed Elizabeth’s life. These cancers are often neglected by researchers due to the small numbers of cases. But for families struggling with this diagnosis, research studies to find these personalized treatments are a matter of life and death.
We thank you for your support.